CLINICAL_TRIALS
trial_result
· 2022-04-25
Clinical Trial Update: Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder Cancer [Phase 1, Phase 2]
Summary
Clinical trial update for avelumab plus BCG in non-muscle invasive bladder cancer (Phase 1/2) with completed status and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Oklahoma | Conditions: Bladder Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-04-25